MedGemma 1.5 is a major upgrade to our open models for healthcare developers. The new 4B model enables developers to build applications that natively interpret full 3D scans (CTs, MRIs) with high efficiency - a first, we believe, for an open medical generalist model. MedGemma

Excited to announce the Cancer Research Institute Discovery Engine — a groundbreaking open, AI-enabled database poised to accelerate cancer immunotherapy Capturing drug-immune-tumor interactions with single-cell + spatial resolution across models and patients. Including drug

https://t.co/DUMWmMyasC

Can we design mutations that predictably bias proteins towards desired conformational states? Today in @ScienceMagazine, we introduce Conformational Biasing (CB), a simple and scalable computational method that uses contrastive scoring by inverse folding models to identify

Predicting cell state in previously unseen conditions such as disease or in response to a drug has typically required retraining for each new biological context. Today, Arc is releasing Stack, a foundation model that learns to simulate cell state under novel conditions directly

The new year marks a new era: Somite is now Cellular Intelligence. This is a statement of what we are building: the first universal virtual cell signaling-model to understand, predict, and control cell behavior. To mark this moment, we’re releasing a white paper sharing

now, let’s get rid of socialism at home.

We need more rugged individualism, not less. Build on the frontier. Be independent. Decentralize power. Accelerate civilizational progress. Celebrate economic freedom.

Venezuela used to be twice as wealthy as Chile. Then Chile adopted free-market principles while Venezuela chose socialism. Now Chile is the wealthiest large country in South America and Venezuela the poorest. Free markets work, socialism makes nations poor.

Primary T cells with multiple genetic modifications are rapidly isolated by negative selection https://t.co/p4OXzMT8oU https://t.co/DuBlj1RPBw

Neuralink will start high-volume production of brain-computer interface devices and move to a streamlined, almost entirely automated surgical procedure in 2026. Device threads will go through the dura, without the need to remove it. This is a big deal.

US: We need to use AI to design molecules faster. China: We can brute force any target designed, into clinic, and sold to big pharma faster than you can clear an IND.

Insightful read on how @BridgeBioPharma pursues genetic diseases, utilizing the predictability of genetic science as a financial instrument to lower the Cost of Capital (WACC) thus maximize Quality-Adjusted Life Years (QALYs) per dollar invested. https://t.co/GixamX5hJy

This is the way

MUST READ from the WSJ: “Something is profoundly wrong with the U.S. welfare system—a problem that runs far deeper and is more dangerous than the shocking fraud in Minnesota that has been making headlines… real federal welfare spending has soared by 765%, more than twice as fast

On Wednesday evening, a monumental pediatric cancer bill made it to the Senate floor—the last hurdle before passage. Cancer victims watched in the gallery. Sibling survivors too. And then... it failed. Because of one vote. Bernie Sanders'. Here's why. https://t.co/j6zfxvJxTm

My CISO called me at 3 AM last Tuesday. "We caught someone." I asked, "Caught them doing what?" He said, "Typing." Let me explain. We have an employee in IT. Great worker. Always online. Never complained. Perfect Slack etiquette. One problem. His keystrokes were arriving

Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction. ctDNA kinetics reveal insights into the timing, risk, and anatomical pattern of relapses —> adaptive treatment recommendations in early stage NSCLC

"The most important thing in the next 3-4 years is data centers in space. In every way, data centers in space, from a first principles perspective, are superior to data centers on earth. In space, you can keep a satellite in the sun 24 hours a day. The sun is 30% more intense,

T cell engagers have demonstrated efficacy in 'cold' tumors, but where do the T cells come from? and how can we improve response? With @SageJulien and Chris Garcia, we show that TCEs recruit new T cell clones to the tumor, ala PD-1 blockade, and can be improved with cytokine